Chevy Chase Trust
AGN

Chevy Chase Trust’s Allergan plc AGN Stock Holding History

Chevy Chase Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-279,347
Closed -$49.5M – 660
2020
Q1 		$49.5M Buy
279,347
+4,742
+2% +$893K 0.23% 102
2019
Q4 		$52.5M Buy
274,605
+574
+0.2% +$104K 0.2% 120
2019
Q3 		$46.1M Buy
274,031
+16,802
+7% +$2.74M 0.19% 123
2019
Q2 		$43.1M Sell
257,229
-3,914
-1% -$542K 0.18% 128
2019
Q1 		$38.4M Sell
261,143
-129
-0% -$18.7K 0.16% 144
2018
Q4 		$34.9M Sell
261,272
-1,085
-0.4% -$178K 0.17% 137
2018
Q3 		$50M Sell
262,357
-23,278
-8% -$4.28M 0.21% 111
2018
Q2 		$47.6M Buy
285,635
+6,151
+2% +$987K 0.21% 112
2018
Q1 		$47M Sell
279,484
-9,382
-3% -$1.57M 0.21% 114
2017
Q4 		$47.3M Sell
288,866
-3,231
-1% -$580K 0.2% 120
2017
Q3 		$59.9M Buy
292,097
+1,479
+0.5% +$344K 0.27% 92
2017
Q2 		$70.6M Buy
290,618
+632
+0.2% +$149K 0.34% 71
2017
Q1 		$69.3M Sell
289,986
-24,522
-8% -$5.71M 0.34% 73
2016
Q4 		$66M Sell
314,508
-16,594
-5% -$3.44M 0.35% 67
2016
Q3 		$76.3M Sell
331,102
-10,052
-3% -$2.46M 0.42% 56
2016
Q2 		$78.8M Buy
341,154
+5,657
+2% +$1.3M 0.44% 51
2016
Q1 		$89.9M Buy
335,497
+8,063
+2% +$2.31M 0.51% 48
2015
Q4 		$102M Buy
327,434
+2,539
+0.8% +$756K 0.6% 38
2015
Q3 		$88.3M Buy
324,895
+12,135
+4% +$3.73M 0.55% 40
2015
Q2 		$94.9M Buy
312,760
+5,439
+2% +$1.62M 0.57% 40
2015
Q1 		$91.5M Buy
307,321
+105,591
+52% +$30.1M 0.55% 40
2014
Q4 		$51.9M Sell
201,730
-1,202
-0.6% -$300K 0.32% 77
2014
Q3 		$49M Buy
202,932
+75,707
+60% +$16.9M 0.32% 76
2014
Q2 		$28.4M Sell
127,225
-1,044
-0.8% -$216K 0.2% 133
2014
Q1 		$26.4M Buy
+128,269
New +$25.4M 0.19% 137
2013
Q4 		– Sell
-97,775
Closed -$14.1M – 664
2013
Q3 		$14.1M Buy
+97,775
New +$13M 0.11% 204

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Chevy Chase Trust's AGN Position: Q2 2020 in Review

Chevy Chase Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 279,347 shares — an estimated $49.5M sold.

Chevy Chase Trust first reported a position in AGN in Q3 2013 and held it in 26 quarters. The position peaked at $102M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Chevy Chase Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Chevy Chase Trust sold 279,347 Allergan plc shares in Q2 2020, an estimated $49.5M.
  • Chevy Chase Trust first reported a position in Allergan plc in Q3 2013 and held it in 26 quarters.
  • Chevy Chase Trust's Allergan plc position peaked at $102M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Chevy Chase Trust's 13F filing for Q2 2020, filed 14 Aug 2020.